AstraZeneca to buy U.S.-based CinCor Pharma in deal valued at $1.3 billion
AstraZeneca PLC said Monday that it has agreed to buy CinCor Pharma, Inc., acquiring global rights to the latter's baxdrostat cardiorenal drug for an upfront transaction value of around $1.3 billion.
The Anglo-Swedish pharma giant said that it will initiate a tender offer to acquire all of U.S.-listed clinical-stage biopharmaceutical company CinCor's outstanding shares, for a price of $26 a share in cash at the closing of the deal, along with a non-tradable contingent value right of $10 a share in cash payable upon a specified regulatory submission of a baxdrostat product. The deal is expected to close in the first quarter.
The upfront cash portion of the acquisition represents a 121% premium to CinCor's closing market price on Jan. 6 of $11.78. The combined upfront and maximum potential contingent value payments represent a transaction value of around $1.8 billion. AstraZeneca said the acquisition will bolster its cardiorenal pipeline by adding baxdrostat, an inhibitor for blood pressure lowering in treatment-resistant hypertension.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Future teachers can earn a degree for free in ArizonaThe Arizona Teachers Academy scholarship offers tuition coverage for students who agree to teach in Arizona.
続きを読む »
Report: Saints, Michael Thomas Agree to Restructured ContractThe Saints and wide receiver Michael Thomas agreed to a restructured contract that creates a potential deadline for the team to decide whether to bring him back next year
続きを読む »
Will Southwest Airlines’ meltdown crash the airline’s 51-year reputation?While it threatens the Dallas-based company’s stature as one of America’s most beloved airlines, experts and analysts agree: Southwest holds the cards to own...
続きを読む »
Advice | Carolyn Hax: Fiance wants a big family. She says maybe two kids — max.A couple can’t agree on how many children to have. Do you need to figure that out before getting married?
続きを読む »
Letter: Changes needed in selecting judgesAn Antioch letter to the editor: I agree with the changes supported by the Daily Herald and the reasons for them.
続きを読む »